PHARMA MANAGEMENT SOLUTIONS - Company finances
|
EUR
|
2018
From: 2018-03-16
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 8,817 | 39,132 | 64,107 | 89,770 | 97,462 | 220,588 | 173,847 | 328,726 |
| Profit before tax | 6,985 | -734 | 15,584 | 17,489 | 10,346 | 48,157 | 11,438 | 47,272 |
| Net profit | 5,937 | -734 | 13,356 | 14,761 | 6,537 | 40,684 | 4,752 | 37,921 |
| Equity | 8,437 | 7,703 | 21,059 | 35,820 | 42,357 | 83,041 | 87,792 | 125,713 |
| Liabilities | 1,476 | 5,184 | 46,175 | 69,732 | 72,480 | 136,493 | 122,803 | 65,354 |
| Non-current assets | 0 | 0 | 0 | 352 | 1,118 | 9,425 | 6,771 | 3,697 |
| Current assets | 9,913 | 12,887 | 67,234 | 105,200 | 101,819 | 305,209 | 203,924 | 187,370 |
| Total assets | 9,913 | 12,887 | 67,234 | 105,552 | 102,937 | 314,634 | 210,695 | 191,067 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 22,549 | 15,441 | 5,981 |
| Social insurance contributions | - | - | - | - | - | 437 | 9,796 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +343.8% | +63.8% | +40.0% | +8.6% | +126.3% | -21.2% | +89.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 59.9% | -5.7% | 19.9% | 14.0% | 6.4% | 12.9% | 2.3% | 19.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 70.4% | -9.5% | 63.4% | 41.2% | 15.4% | 49.0% | 5.4% | 30.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 67.3% | -1.9% | 20.8% | 16.4% | 6.7% | 18.4% | 2.7% | 11.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 79.2% | -1.9% | 24.3% | 19.5% | 10.6% | 21.8% | 6.6% | 14.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.7 | 2.2 | 1.9 | 1.7 | 1.6 | 1.4 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,817 | 21,345 | 29,587 | 44,885 | 34,399 | 91,277 | 40,905 | 116,022 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PHARMA MANAGEMENT SOLUTIONS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-16 | 2025-06-04 | 0.52 |
| 2025-05-04 | 2025-05-08 | 0.52 |
| 2025-04-24 | 2025-04-29 | 0.52 |
| 2025-01-16 | 2025-01-19 | 387.30 |
| 2024-08-19 | 2024-08-20 | 713.22 |
PHARMA MANAGEMENT SOLUTIONS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PHARMA MANAGEMENT SOLUTIONS, UAB (code 304787794) is a Private Limited Liability Company engaged in other software publishing. In 2025, the company generated revenue of EUR 328.7K, up 89.1% year on year and 49.0% over two years. Net profit reached EUR 37.9K, compared with EUR 4.8K in 2024 and EUR 40.7K in 2023, showing a strong recovery after a weaker prior year. Profit margin improved to 11.5% in 2025 from 2.7% in 2024, though it remained below the 18.4% level recorded in 2023. The balance sheet shows total assets of EUR 191.1K, equity of EUR 125.7K and liabilities of EUR 65.4K at the end of 2025. Compared with 2024, equity strengthened while liabilities declined. Key indicators for 2025 include ROE of 30.2%, ROA of 19.9%, debt-to-equity of 0.52 and asset turnover of 1.72x. Revenue per employee was EUR 164.4K and profit per employee was EUR 19.0K, indicating relatively strong productivity.